The effect of endogenous altered peptide ligands on peripheral T-cell responses

Seminars in Immunology

Volumn 8, Issue 2, 1996, Pages 117-122

  Vidal, Karine ^a   Allen, Paul M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Altered peptide ligands; Partial T cell activation; Self antigen; T cell development; T cell receptor antagonists

Indexed keywords

AUTOANTIGEN; LIGAND; T LYMPHOCYTE RECEPTOR;

CELLULAR IMMUNITY; PERIPHERAL LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029983373     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0014     Document Type: Short Survey

References (44)

1. Evavold BD, Allen PM (1991) Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308-1310
2. Windhagen A, Scholz C, Höllsberg P, Fukaura H, Sette A, Hafler DA (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373-380
3. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM (1994) Partial T cell signaling: Altered phospho-ζ and lack of Zap 70 recruitment in APL-induced T cell anergy. Cell 79:913-922
4. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN (1995) ζ Phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515-518
5. Sloan-Lancaster J, Evavold BD, Allen PM (1993) Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156-159
6. Sloan-Lancaster J, Evavold BD, Allen PM (1994) Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 180:1195-1205
7. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FCA, Grey HM, Sette A (1992) Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625-634
8. Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 177:1541-1550
9. Racioppi L, Ronchese F, Matis LA, Germain RN (1993) Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med 177:1047-1060
10. Evavold BD, Sloan-Lancaster J, Allen PM (1993) Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc Natl Acad Sci USA 91:2300-2304
11. Ruppert J, Alexander J, Snoke K, Coggeshall M, Herbert E, McKenzie D, Grey HM, Sette A (1993) Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc Natl Acad Sci USA 90:2671-2675
12. Mannie MD, Rosser JM, White GA (1995) Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J Immunol 154:2642-2654
13. Spain LM, Jorgensen JL, Davis MM, Berg LJ (1994) A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol 152:1709-1717
14. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27
15. Ashton-Richardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher H-P, Zinkernagel RM, Tonegawa S (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651-663
16. Sebzda E, Wallace VA, Mayer J, Yeung RSM, Mak TW, Ohashi PS (1994) Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615-1618
17. + T cells. Immunity 3:79-86
18. + thymocytes by T-cell receptor peptide antagonists. Proc Natl Acad Sci USA 91:4057-4061
19. Barnden MJ, Heath WR, Rodda S, Carbone FR (1994) Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol 24:2452-2456
20. Jameson SC, Hogquist KA, Bevan MJ (1994) Specificity and flexibility in thymic selection. Nature 369:750-752
21. Evavold BD, Sloan-Lancaster J, Allen PM (1993) Tickling the TCR: Selective T cell functions stimulated by altered peptide ligands. Immunol Today 14:602-609
22. Sette A, Alexander J, Ruppert J, Snoke D, Franco A, Ishioka G, Grey HM (1994) Antigen analogs/ MHC complexes as specific T cell receptor antagonists. Annu Rev Immunol 12:413-431
23. Jameson SC, Bevan MJ (1995) T cell receptor antagonists and partial agonists. Immunity 2:1-11
24. Sloan-Lancaster J, Allen PM (1995) Sgnificance of T-cell stimulation by altered peptide ligands in T cell biology. Curr Opin Immunol 7:103-109
25. Hsu BL, Evavold BD, Allen PM (1995) Modulation of T cell development by an endogenous altered peptide ligand. J Exp Med 181:805-810
26. Lorenz RG, Allen PM (1988) Direct evidence for functional self protein/ Ia-molecule complexes in vivo. Proc Natl Acad Sci USA 85:5220-5223
27. Evavold BD, Williams SG, Hsu BL, Buus S, Allen PM (1992) Complete dissection of the Hb(64-76) determinant using Th1, Th2 clones, and T cell hybridomas. J Immunol 148:347-353
28. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM (1995) Specific T cell recognition of minimally homologous peptides evidence for multiple endogenous ligands. Immunity 2:655-663
29. Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705
30. Lorenz RG, Allen PM (1989) Thymic cortical epithelial cells lack full capacity for antigen presentation. Nature 340:557-559
31. Lorenz RG, Allen PM (1989) Thymic cortical epithelial cells can present self antigens in vivo. Nature 337:560-562
32. Marrack P, Ignatowicz L, Kappler JW, Boymel J, Freed JH (1993) Comparison of peptides bound to spleen and thymus class II. J Exp Med 178:2173-2183
33. Yagi J, Janeway Jr CA (1990) Ligand thresholds at different stages of T cell development. Int Immunol 2:83-89
34. Pircher H, Rohrer UH, Moskophidis D, Zinkernagel RM, Hengartner H (1991) Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351:482-485
35. Vasquez NJ, Kane LP, Hedrick SM (1994) Intracellular signals that mediate thymic negative selection. Immunity 1:45-56
36. D'Ambrosio D, Hippen KL, Minskoff SA, Mellman I, Pani G, Siminovitch KA, Cambier JC (1995) Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 268:293-297
37. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT (1995) Restriction of B lymphocyte activation by CD22 and the protein tyrosine phosphatase, SH P. Science 269:242-244
38. Weiss S, Bogen B (1989) B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 86:282-286
39. Bikoff EK, Eckhardt LA (1989) Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells. Eur J Immunol 19:1903-1909
40. H epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 179:195-202
41. Davenport MP (1995) Antagonists or altruists: do viral mutants modulate T-cell responses? Immunol Today 16:432-436
42. Allen PM, Zinkernagel RM (1994) Promethean viruses? Nature 369:355-356
43. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Köppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ (1994) Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403-407
44. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells. Nature 369:407-410